Earnings & Reporting

Adhesives giant H.B. Fuller expands margins and raises its 2026 outlook, signaling operational strength amid market softness and supply chain turmoil.

The MEMS specialist saw revenue dip on a sharp medical decline, but booming aerospace sales, a higher margin, and a new dividend signal a strategic pivot.

A new report reveals a stark divide: while independent hotels struggle with declining revenue and OTA pressure, strategic shifts and tech offer a path forward.

In a strategic play, VIVUS is slashing the price of its oral obesity drug QSIVA, challenging the dominance of costly new injectables like Wegovy.

The firm's top spot in the Dallas Business Journal ranking highlights its regional dominance, but what does it mean for local investors and the DFW economy?

With a record $5.8B in revenue, telecom giant Millicom is aggressively buying up assets in Latin America, reshaping the market as rivals retreat.

Krispy Kreme secures $160M in deals by refranchising U.S. and Japan shops, pivoting to a capital-light model to slash debt and fuel growth.

Rithm Capital declared its 52nd straight dividend. Is its high yield and analyst praise enough to overcome recent stock woes and market skepticism?

In a decisive move to strengthen its balance sheet, the essential minerals firm is using cash on hand to retire debt early, boosting investor confidence.

With a major acquisition pending and strong 2025 momentum, all eyes are on Associated Banc-Corp's upcoming Q1 results for signs of regional bank health.

Banks have quadrupled digital spending, yet customers are less happy. A new 'signal-driven' approach is changing that, and one bank's 2000% growth proves it.

The non-prime lender struck a deal with lenders to ensure liquidity, but it comes at a high price amid massive loan losses and scrutiny of its LendCare unit.

Investors eye Cardinal Health's April 30 report for signs its aggressive diversification and specialty pharma push can sustain its powerful earnings momentum.

Two major US investors build significant stakes in AI-native platform Sidetrade, signaling a wider trend of American capital chasing European tech innovation.

A new partnership brings US-made, mission-critical power semiconductors to a wider market, aiming to bolster defense, energy, and transport industries.

Singapore's HomesToLife nearly doubles its net profit, fueled by a key acquisition and strong exports, defying global market headwinds that have hit rivals.

Facing financial pressure, Sleep Number launches its biggest product overhaul in a decade, hoping simpler choices and new tech can win back customers.

Founder Dr. Bill Rivard moves to Chairman as veteran Tricia Brown takes the helm, signaling a new era for military healthcare staffing.

With a new $1 billion war chest from J.P. Morgan and Morgan Stanley, Core Scientific is racing to convert its crypto mines into AI data centers.

Tech and governance expert Ekta Singh-Bushell will not seek re-election to Huron's board, marking a key transition for the firm's digital strategy.